Envista Holdings Corporation (NVST)
| Market Cap | 4.35B +30.2% |
| Revenue (ttm) | 2.81B +12.1% |
| Net Income | 67.70M |
| EPS | 0.41 |
| Shares Out | 162.73M |
| PE Ratio | 65.55 |
| Forward PE | 18.53 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,786,346 |
| Open | 26.71 |
| Previous Close | 26.99 |
| Day's Range | 26.61 - 27.31 |
| 52-Week Range | 18.77 - 30.42 |
| Beta | 0.86 |
| Analysts | Buy |
| Price Target | 29.43 (+10.06%) |
| Earnings Date | Aug 5, 2026 |
About NVST
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, ... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 16 analysts, the average rating for NVST stock is "Buy." The 12-month stock price target is $29.43, which is an increase of 10.06% from the latest price.
News
Envista initiated with a Market Perform at BMO Capital
BMO Capital analyst Vik Chopra initiated coverage of Envista (NVST) with a Market Perform rating and $27 price target The company’s turnaround is real and its CEO has earned credibility,…
Envista Schedules Second Quarter 2026 Earnings Call
BREA, Calif., July 7, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its second quarter 2026 on Wednesday, August 5, 2026.
Envista price target lowered to $32 from $34 at Barclays
Barclays lowered the firm’s price target on Envista (NVST) to $32 from $34 and keeps an Overweight rating on the shares. The firm says the company’s end markets continue to…
Envista Holdings Transcript: AGM 2026
The meeting covered board elections, auditor ratification, and executive compensation, with all proposals passing by majority vote. A quorum was present, and no stockholder questions were submitted during the Q&A session.
Envista price target raised to $31 from $30 at Baird
Baird analyst Jeff Johnson raised the firm’s price target on Envista (NVST) to $31 from $30 and keeps an Outperform rating on the shares. The firm updated its model following…
Envista price target raised to $29 from $26 at JPMorgan
JPMorgan raised the firm’s price target on Envista (NVST) to $29 from $26 and keeps a Neutral rating on the shares.
Envista price target raised to $33 from $30 at Evercore ISI
Evercore ISI analyst Elizabeth Anderson raised the firm’s price target on Envista (NVST) to $33 from $30 and keeps an Outperform rating on the shares.
Envista Holdings Earnings Call Transcript: Q1 2026
Q1 2026 saw double-digit sales, adjusted EBITDA, and EPS growth, driven by broad-based segment and geographic performance. Operational improvements and continued investment in innovation supported margin expansion, while the board authorized a $300 million share repurchase and reaffirmed 2026 guidance.
Envista Holdings Earnings release: Q1 2026
Envista Holdings released its Q1 2026 earnings on May 6, 2026, summarizing the period's financial results.
Envista Holdings Quarterly report: Q1 2026
Envista Holdings has published its Q1 2026 quarterly earnings report on May 6, 2026.
Envista Holdings Slides: Q1 2026
Envista Holdings has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 6, 2026.
Envista Reports First Quarter 2026 Results
BREA, Calif., May 6, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) today announced results for the quarter ended April 3, 2026.
Envista price target raised to $21 from $19 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Envista (NVST) to $21 from $19 and keeps an Equal Weight rating on the shares. The firm’s U.S. dental survey suggests softer…
Envista initiated with a Neutral at Citi
Citi analyst Daniel Grosslight initiated coverage of Envista (NVST) with a Neutral rating and $29 price target The firm launched the animal health and dental sectors with a “cautiously optimistic”…
Envista Schedules First Quarter 2026 Earnings Call
BREA, Calif., April 8, 2026 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its first quarter 2026 on Wednesday, May 6, 2026.
Envista price target lowered to $30 from $32 at Evercore ISI
Evercore ISI lowered the firm’s price target on Envista (NVST) to $30 from $32 and keeps an Outperform rating on the shares. The firm made several price target adjustments and…
Envista Holdings Proxy statement: Proxy filing
Envista Holdings filed a proxy statement on April 7, 2026, providing details for shareholder voting and corporate governance matters.
Envista Holdings Proxy statement: Proxy filing
Envista Holdings filed a proxy statement on April 7, 2026, providing details for shareholder voting and corporate governance matters.
Envista price target raised to $32 from $28 at BofA
BofA analyst Allen Lutz raised the firm’s price target on Envista (NVST) to $32 from $28 and keeps a Buy rating on the shares. Following earnings, the firm is raising…
Envista price target raised to $30 from $27 at Baird
Baird raised the firm’s price target on Envista (NVST) to $30 from $27 and keeps an Outperform rating on the shares. The firm updated its model following solid results driven…
Envista price target raised to $19 from $18 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Envista (NVST) to $19 from $18 and keeps an Equal Weight rating on the shares. Q4 upside and 2026 guidance were “encouraging,”…
Envista price target raised to $32 from $26 at Evercore ISI
Evercore ISI analyst Elizabeth Anderson raised the firm’s price target on Envista (NVST) to $32 from $26 and keeps an Outperform rating on the shares following EBITDA and EPS beats…
Envista price target raised to $31 from $27 at Stifel
Stifel raised the firm’s price target on Envista (NVST) to $31 from $27 and keeps a Buy rating on the shares. The company seems to be growing market plus across…
Envista price target raised to $26 from $22 at JPMorgan
JPMorgan raised the firm’s price target on Envista (NVST) to $26 from $22 and keeps a Neutral rating on the shares. The company reported strong Q4 results with “reasonable” 2026…
Envista price target raised to $25 from $21 at Piper Sandler
Piper Sandler analyst Jason Bednar raised the firm’s price target on Envista (NVST) to $25 from $21 and keeps a Neutral rating on the shares. The firm notes Q4 was…